Relevant to liver cancer, a positive impact of DC vaccines on NK cells, characterized by increased expression of the activation markers CD25 and CD69 on circulating NK cells, was also reported in murine models of liver cancer [211,212,213] and in HCC patients [214]. This evidence concerns the gene CD69 and liver cancer.